Table 1.
Characteristic | HIV+, n=1636 | HIV−, n=72,297 | P Value |
---|---|---|---|
Transplant era | <0.001 | ||
1997–2004 | 268 (16.4%) | 18,227 (25.2%) | |
2005–2008 | 641 (39.2%) | 26,568 (36.8%) | |
2009–2012 | 727 (44.4%) | 27,502 (38.0%) | |
Age, yr | <0.001 | ||
18–34 | 155 (9.5%) | 5976 (8.3%) | |
35–49 | 871 (53.2%) | 21,155 (29.3%) | |
50–64 | 562 (34.4%) | 33,167 (45.9%) | |
65+ | 48 (2.9%) | 11,999 (16.6%) | |
Sex | <0.001 | ||
Men | 1231 (75.2%) | 42,840 (59.3%) | |
Women | 405 (24.8%) | 29,457 (40.7%) | |
Race | <0.001 | ||
Non-Hispanic white | 271 (16.6%) | 36,883 (51.0%) | |
Black | 1204 (73.6%) | 20,145 (27.9%) | |
Hispanic | 140 (8.6%) | 10,254 (14.2%) | |
Other | 21 (1.3%) | 5015 (6.9%) | |
Cause of kidney disease | <0.001 | ||
Diabetes | 239 (14.6%) | 23,519 (32.5%) | |
Hypertension | 529 (32.3%) | 16,756 (23.2%) | |
GN | 169 (10.3%) | 12,508 (17.3%) | |
Other | 699 (42.7%) | 19,514 (27.0%) | |
Poor functional statusa | 88 (5.4%) | 4647 (6.4%) | 0.09 |
PRA>80% | 130 (8.0%) | 8277 (11.5%) | <0.001 |
Willing to accept HCV+ kidney | 147 (9.0%) | 2845 (3.9%) | <0.001 |
Willing to accept ECD kidney | 689 (42.1%) | 34,058 (47.1%) | <0.001 |
Blood group type | <0.001 | ||
A | 471 (28.8%) | 24,697 (34.2%) | |
AB | 54 (3.3%) | 2984 (4.1%) | |
B | 304 (18.6%) | 10,387 (14.4%) | |
O | 807 (49.3%) | 34,229 (47.3%) | |
Status on waiting list | <0.001 | ||
Always inactive on the list | 205 (12.5%) | 6508 (9.0%) | |
Started inactive but active at least once | 248 (15.2%) | 9742 (13.5%) | |
Started active but inactive at least once | 566 (34.6%) | 20,327 (28.1%) | |
Always active | 617 (37.7%) | 35,720 (49.4%) | |
Diabetes | 368 (22.5%) | 31,061 (43.0%) | <0.001 |
BMI, kg/m2 | <0.001 | ||
<20 | 91 (5.6%) | 2546 (3.5%) | |
20≤BMI<25 | 581 (35.5%) | 16,314 (22.6%) | |
25≤BMI<30 | 537 (32.8%) | 23,845 (33.0%) | |
30≤BMI<35 | 244 (14.9%) | 16,818 (23.3%) | |
≥35 | 136 (8.3%) | 11,159 (15.4%) | |
Missing | 47 (2.9%) | 1615 (2.2%) | |
Peripheral vascular disease | 35 (2.1%) | 3620 (5.0%) | <0.001 |
Years on dialysis at the time of listing | 2.5 (0.9–5.4) | 0.8 (0–2.1) | <0.001 |
Dialysis at listing, yr | <0.001 | ||
0 | 158 (9.7%) | 18,721 (25.9%) | |
<1 | 284 (17.4%) | 22,829 (31.6%) | |
1 to <2 | 265 (16.2%) | 11,988 (16.6%) | |
2 to <3 | 209 (12.8%) | 5214 (7.2%) | |
3 to <4 | 159 (9.7%) | 2818 (3.9%) | |
4 to <6 | 199 (12.2%) | 3036 (4.2%) | |
6 to <11 | 267 (16.3%) | 3445 (4.8%) | |
11+ | 95 (5.8%) | 4246 (5.9%) | |
Insurance type | |||
Medicare | 1009 (61.7%) | 31,546 (43.6%) | |
Medicaid | 153 (9.4%) | 5456 (7.6%) | |
Private/self | 452 (27.6%) | 34,550 (47.8%) | |
Other | 22 (1.3%) | 745 (1.0%) | |
Region | <0.001 | ||
1 | 70 (4.3%) | 2629 (3.6%) | |
2 | 433 (26.5%) | 11,479 (15.9%) | |
3 | 217 (13.3%) | 8865 (12.3%) | |
4 | 57 (3.5%) | 4520 (6.3%) | |
5 | 240 (14.7%) | 14,043 (19.4%) | |
6 | 16 (1.0%) | 2100 (2.9%) | |
7 | 118 (7.2%) | 6851 (9.5%) | |
8 | 27 (1.7%) | 3399 (4.7%) | |
9 | 228 (13.9%) | 6092 (8.4%) | |
10 | 94 (5.8%) | 6789 (9.4%) | |
11 | 136 (8.3%) | 5530 (7.7%) |
PRA, panel reactive antibody; HCV+, hepatitis C virus seropositive; ECD, expanded criteria donor; BMI, body mass index.
Poor functional status defined as hospitalization, use of wheelchair, or limited mobility.